ConductScience.org, home
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
API referenceFor AI assistants

Trial · NCT01877915

Adverse events1,048

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,048

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherNasopharyngitisInfections and infestationsRivaroxaban532,507
otherNasopharyngitisInfections and infestationsPlacebo602,515
seriousAnaemiaBlood and lymphatic system disordersRivaroxaban122,507
seriousAnaemiaBlood and lymphatic system disordersPlacebo72,515
seriousAnaemia Vitamin B12 DeficiencyBlood and lymphatic system disordersRivaroxaban12,507
seriousAnaemia Vitamin B12 DeficiencyBlood and lymphatic system disordersPlacebo02,515
seriousAplastic AnaemiaBlood and lymphatic system disordersRivaroxaban02,507
seriousAplastic AnaemiaBlood and lymphatic system disordersPlacebo12,515
seriousDisseminated Intravascular CoagulationBlood and lymphatic system disordersRivaroxaban02,507
seriousDisseminated Intravascular CoagulationBlood and lymphatic system disordersPlacebo12,515
seriousIron Deficiency AnaemiaBlood and lymphatic system disordersRivaroxaban02,507
seriousIron Deficiency AnaemiaBlood and lymphatic system disordersPlacebo12,515
seriousLymphadenopathyBlood and lymphatic system disordersRivaroxaban02,507
seriousLymphadenopathyBlood and lymphatic system disordersPlacebo12,515
seriousThrombocytopeniaBlood and lymphatic system disordersRivaroxaban02,507
seriousThrombocytopeniaBlood and lymphatic system disordersPlacebo32,515
seriousAtrial FibrillationCardiac disordersRivaroxaban12,507
seriousAtrial FibrillationCardiac disordersPlacebo02,515
seriousCardiac FailureCardiac disordersRivaroxaban02,507
seriousCardiac FailureCardiac disordersPlacebo12,515

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01877915/events

API referenceFor AI assistants